The stock of Biocryst Pharmaceuticals Inc (BCRX) has gone up by 7.52% for the week, with a 2.96% rise in the past month and a
The stock of Biocryst Pharmaceuticals Inc (BCRX) has gone down by -4.04% for the week, with a 1.60% rise in the past month and a
BCRX has 36-month beta value of 1.74. Analysts have mixed views on the stock, with 4 analysts rating it as a “buy,” 6 as “overweight,”
The stock of Biocryst Pharmaceuticals Inc (BCRX) has seen a 7.05% increase in the past week, with a 5.78% gain in the past month, and
BioCryst Pharmaceuticals, Inc. (BCRX), a biotechnology company, is trading at $11.64 in the current market after plunging 34.90% since the start of the trading session.
© 2024, Powered by Smart TechOne
